Bayer yanks Yaz commercial after FDA warning
Monday, February 9, 2009
Bayer halted Yaz advertising after the FDA complained that Bayer was publishing misleading advertising that overstated the drug's ability to improve mood and clear up acne while downplaying health risks.
The FDA then required Bayer to issue "corrective advertising". One of these "corrective advertisements" can be seen below. At issue is whether this rare FDA required "corrective advertising" sufficiently addresses previous misleading advertising.
Meet Mr. Orlando
Current News
Quick Contact
Time is of the essence in these very sensitive cases. Simply use the form below and an Attorney will contact you shortly.
Free Case Evaluation
Find out quickly - with no cost or obligation - if you might be entitled to a large cash settlement. Simply complete the Case Evaluation Form.
